Leila R. Martins - Concepedia

Author

Leila R. Martins

Also Known As

L R Martins, L. R. Martins, L.R. Martins, Leila Martins, Leila R. Martins, Líbyna Thaynara Calandrelli Martins, Martins, Leila R

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Lisbon Deutschen Konsortium für Translationale Krebsforschung Universidade Nova de Lisboa German Cancer Research Center Instituto Gulbenkian de Ciência

About

Leila R. Martins is an author at University of Lisbon specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1K
2	Cell Biology	7	7	1K
3	Immunology	6	6	825
4	Public Health	1	1	27
5	Cellular Physiology	1	1	17

Leila R. Martins

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability Ana Silva, José Andrés Yunes, Bruno A. Cardoso, Journal of Clinical Investigation Pten ActivitySignal TransductionCell RegulationSignaling PathwayReceptor Tyrosine Kinase	2008	441
Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis Inês Sofia Vala, Leila R. Martins, Natsuko Imaizumi, PLoS ONE Radiation EffectRadiation ExposureZebrafish Fin RegenerationRadiation BiologyTumor Biology	2010	183
IL-7 Contributes to the Progression of Human T-cell Acute Lymphoblastic Leukemias Ana Silva, Angelo B. A. Laranjeira, Leila R. Martins, Cancer Research Hematological MalignancyMicroenvironmental FactorsAutoimmune DiseaseLymphocyte DevelopmentImmune Cell Development	2011	140
Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels Ana Margarida Gomes, Maria V. D. Soares, Patrick Rasmussen Ribeiro, Haematologica Protein Kinase Ck2Mixed-phenotype Acute LeukemiaImmunologyCell DeathPten Protein Stabilization	2014	84
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling Francesca Buontempo, Ester Orsini, Leila R. Martins, Leukemia Hematological MalignancyInhibitor Cx-4945Receptor Tyrosine KinaseMalignant Blood DisorderImmunology	2013	81
Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia Leila R. Martins, Paulo Lúcio, Milene Costa da Silva, Blood	2010	69
CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress Leonor M. Sarmento, Vanda Póvoa, R. Nascimento, Oncogene Hematological MalignancyChromatinExcessive Replication StressMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2014	62
Highly Active Microbial Phosphoantigen Induces Rapid yet Sustained MEK/Erk- and PI-3K/Akt-Mediated Signal Transduction in Anti-Tumor Human γδ T-Cells Daniel V. Correia, Francisco d’Orey, Bruno A. Cardoso, PLoS ONE	2009	48
Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival Kolja Pocha, Andreas Möck, Carmen Rapp, Clinical Cancer Research	2020	37
Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor Leila R. Martins, Yasser Perera, Paulo Lúcio, Oncotarget	2013	36

Page 1